about
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repressionAffinity-based proteomics reveal cancer-specific networks coordinated by Hsp90DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaTet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformationDeletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoPRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex.Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locusLoss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasisDiamidine compounds for selective inhibition of protein arginine methyltransferase 1.The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand.The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation.JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation.The mef/elf4 transcription factor fine tunes the DNA damage response.Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.Depletion of L3MBTL1 promotes the erythroid differentiation of human hematopoietic progenitor cells: possible role in 20q- polycythemia veraDefining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification
P50
Q24296658-BBAE70D4-5887-4B4B-8CD1-FCC0A696015DQ28249103-C5BE50D3-A1B1-4FC1-A3E0-759803F53EADQ28253465-DC2AAFA0-2B90-4BB3-8F39-0D19806914B2Q28508217-E88D7274-3F9D-412F-9380-B11D6F86DFB5Q30413034-2D523986-9D65-4DEB-AA5A-55E538F60DF9Q33815742-FF2D2645-5449-46F8-8E26-92049E49F38FQ33824979-E6108873-5E35-4011-9E4F-02D0546D833EQ35650662-77022B0D-4F63-4F25-8E34-D7EB5E3F2B6BQ37201056-88CA0A2E-3E57-42FE-98F7-28EA37289322Q37201706-B75ED601-4DED-493C-B2FB-6C85F2D3913FQ37697338-AF3492F8-96C1-42D8-BA65-7DA4B0E82670Q38704582-B7AF3C20-DE85-4C52-A661-A21366625C5FQ38775132-0183E5CE-25A0-4513-B09C-D5F783A3B2C9Q39593309-C7194F09-99DA-489B-8494-85B9B00399C8Q41375377-A2EE2D66-8BCF-4392-ADF9-14276ACA0500Q42069894-CF507DEB-BA45-4B03-84EE-0C45756105C7Q42379870-D419F42B-BCB7-42D7-8E97-59BE841CE89FQ58076957-FBA27B36-16DE-484F-B1B2-00363E4DCFD9Q92961315-17152AED-65CB-43D3-B534-05D6DFCB730E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Xinyang Zhao
@ast
Xinyang Zhao
@en
Xinyang Zhao
@es
Xinyang Zhao
@nl
Xinyang Zhao
@sl
type
label
Xinyang Zhao
@ast
Xinyang Zhao
@en
Xinyang Zhao
@es
Xinyang Zhao
@nl
Xinyang Zhao
@sl
prefLabel
Xinyang Zhao
@ast
Xinyang Zhao
@en
Xinyang Zhao
@es
Xinyang Zhao
@nl
Xinyang Zhao
@sl
P106
P1153
36633438000
P31
P496
0000-0001-6677-7072
P569
2000-01-01T00:00:00Z